日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB

更正：S100A9+ MDSC 和 TAM 介导的肺腺癌 EGFR-TKI 耐药性：RELB 的作用

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.25943
Feng, Po-Hao; Yu, Chih-Teng; Chen, Kuan-Yuan; Luo, Ching-Shan; Wu, Shen Ming; Liu, Chien-Ying; Kuo, Lu Wei; Chan, Yao-Fei; Chen, Tzu-Tao; Chang, Chih-Cheng; Lee, Chun-Nin; Chuang, Hsiao-Chi; Lin, Chiou-Feng; Han, Chia-Li; Lee, Wei-Hwa; Lee, Kang-Yun
MDSC
肿瘤
肿瘤免疫
EGF
EGFR
S100A9
RELB
发表日期：2018
文献求助 收藏

Corrigendum: SUV39H1 Reduction Is Implicated in Abnormal Inflammation in COPD

更正：SUV39H1降低与慢性阻塞性肺病中的异常炎症有关

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/srep46924
Chen, Tzu-Tao; Wu, Sheng-Ming; Ho, Shu-Chuan; Chuang, Hsiao-Chi; Liu, Chien-Ying; Chan, Yao-Fei; Kuo, Lu-Wei; Feng, Po-Hao; Liu, Wen-Te; Chen, Kuan-Yuan; Hsiao, Ta-Chih; Juang, Jer-Nan; Lee, Kang-Yun
Immunology/Inflammation
发表日期：2017
文献求助 收藏

SUV39H1 Reduction Is Implicated in Abnormal Inflammation in COPD.

SUV39H1 减少与 COPD 的异常炎症有关

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/srep46667
Chen Tzu-Tao, Wu Sheng-Ming, Ho Shu-Chuan, Chuang Hsiao-Chi, Liu Chien-Ying, Chan Yao-Fei, Kuo Lu-Wei, Feng Po-Hao, Liu Wen-Te, Chen Kuan-Yuan, Hsiao Ta-Chih, Juang Jer-Nan, Lee Kang-Yun
免疫/内分泌
炎症
发表日期：2017
文献求助 收藏